Quantinno Capital Management LP Buys 9,714 Shares of Ralliant Corporation $RAL

Quantinno Capital Management LP grew its stake in Ralliant Corporation (NYSE:RAL) by 15.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 74,021 shares of the company’s stock after buying an additional 9,714 shares during the quarter. Quantinno Capital Management LP owned approximately 0.07% of Ralliant worth $3,079,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in RAL. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Ralliant during the 1st quarter valued at about $3,593,000. Renaissance Technologies LLC increased its holdings in Ralliant by 28.6% in the 1st quarter. Renaissance Technologies LLC now owns 371,082 shares of the company’s stock worth $15,433,000 after acquiring an additional 82,580 shares in the last quarter. Gabelli Funds LLC increased its holdings in Ralliant by 28.2% in the 1st quarter. Gabelli Funds LLC now owns 38,257 shares of the company’s stock worth $1,591,000 after acquiring an additional 8,421 shares in the last quarter. Gamco Investors INC. ET AL raised its stake in Ralliant by 7.9% during the 1st quarter. Gamco Investors INC. ET AL now owns 52,261 shares of the company’s stock worth $2,174,000 after acquiring an additional 3,833 shares during the period. Finally, Bank of Nova Scotia raised its stake in Ralliant by 571.1% during the 1st quarter. Bank of Nova Scotia now owns 162,400 shares of the company’s stock worth $6,754,000 after acquiring an additional 138,200 shares during the period.

Ralliant Trading Up 2.4%

Shares of RAL opened at $67.52 on Friday. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.52 and a quick ratio of 1.00. Ralliant Corporation has a 1 year low of $37.27 and a 1 year high of $75.41. The company has a 50 day simple moving average of $67.63 and a two-hundred day simple moving average of $54.81. The firm has a market cap of $7.47 billion, a P/E ratio of -6.22, a price-to-earnings-growth ratio of 2.51 and a beta of 1.60.

Ralliant (NYSE:RAL) last released its earnings results on Thursday, July 30th. The company reported $0.68 EPS for the quarter, topping the consensus estimate of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The firm had revenue of $567.80 million for the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, equities analysts expect that Ralliant Corporation will post 2.87 earnings per share for the current fiscal year.

Ralliant Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Ralliant’s dividend payout ratio is -1.84%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on RAL. Vertical Research downgraded shares of Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price target on the stock. in a report on Wednesday, May 27th. Evercore initiated coverage on shares of Ralliant in a research report on Tuesday, June 9th. They set an “outperform” rating and a $80.00 price objective on the stock. Truist Financial restated a “buy” rating and set a $82.00 target price (up from $68.00) on shares of Ralliant in a research note on Friday, July 31st. Morgan Stanley upped their target price on shares of Ralliant from $68.00 to $85.00 and gave the stock an “overweight” rating in a report on Tuesday, June 23rd. Finally, Royal Bank Of Canada increased their price target on Ralliant from $71.00 to $73.00 and gave the stock a “sector perform” rating in a research note on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $75.70.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.